Hassan Asadi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Hassan Asadi has a total of 18 co-authors. Here are the top co-authors by number of shared publications:
- Mojgan Sheikhpour
Department of Mycobacteriology and Pulmonary Research, Pasteur Institute of Iran, Tehran, Iran
2 shared publications Abbas Asosheh
Department of Electrical & Computer Engineering, Faculty of Electrical & Computer Engineering, Tarbiat Modares University, Tehran, Iran
1 shared publicationAbolfazl Movafagh
Department of Medical Genetics, Cancer Research Center, Shohada Hospital School of Medicine, Shahid Beheshti University of Medical Science, Tehran, Iran
1 shared publicationAli Mansoori
Department of Life Science Engineering, Faculty of New Sciences and Technologies, University of Tehran, Tehran, Iran
1 shared publicationAlibakhsh Kasaeian
Faculty of New Science and Technologies, University of Tehran, Tehran, Iran
1 shared publication- Azam Bolhassani
Affiliation Department of Hepatitis, AIDS and Blood-borne diseases, Pasteur Institute of Iran, Tehran, Iran
1 shared publication
Latest Publications
- 11 October 2019
- Published by Bentham Science Publishers Ltd. in Protein & Peptide Letters
- Vol. 26 (12) , 930-939
Anti-viral Effects of Superpositively Charged Mutant of Green Fluorescent Protein
Background: Supercharged GFP proteins were known as effective carriers for delivery of macromolecules into eukaryotic cells as well as fluorescent fusion tags for in vitro and in vivo detection. Objective: Herein, anti-viral effects of +36 GFP and its anti-tumor effects were studied in vitro and in vivo, respectively. Method: We evaluated anti-HIV, anti-HSV, and anti-HCV effects of +36 GFP in vitro using ELISA, and real time PCR as common techniques for their detection, respectively. Moreover, we assessed the role of +36 GFP for eliciting HPV-related anti-tumor effects in mice due to the lack of HPV replication in vitro. Results: Our data showed that +36 GFP efficiently enter the cells and augment the transfection rate of HPV16E7 antigen, as well. Furthermore, +36 GFP significantly reduced HCV, HIV and HSV replication up to 75%, 49% and 43% in HCV-infected Huh7.5 cells, HIV-infected Hela cells and HSV-infected Vero cells, respectively. On the other hand, mice immunization with +36 GFP complexed with HPV16 E7 antigen (+36GFP + E7) or fused to HPV16 E7 antigen (+36GFP-E7) elicited a higher Th1 cellular immune response with the predominant IgG2a, IgG2b, IFN-γ and Granzyme B levels than those induced by other groups. These regimens protected mice against TC-1 tumor challenge (~ 67%) compared to E7 protein alone (~ 33%). These data suggested that +36 GFP can act as an anti-viral agent at certain dose due to its high efficiency in cell penetration in vitro and in vivo. Conclusion: Generally, +36 GFP targets viral replication in vitro as well as helps to suppress the growth of HPV-related tumors in vivo.
- 11 October 2019
- Published by Bentham Science Publishers Ltd. in Protein & Peptide Letters
- Vol. 26 (12) , 930-939
Anti-viral Effects of Superpositively Charged Mutant of Green Fluorescent Protein
Background: Supercharged GFP proteins were known as effective carriers for delivery of macromolecules into eukaryotic cells as well as fluorescent fusion tags for in vitro and in vivo detection. Objective: Herein, anti-viral effects of +36 GFP and its anti-tumor effects were studied in vitro and in vivo, respectively. Method: We evaluated anti-HIV, anti-HSV, and anti-HCV effects of +36 GFP in vitro using ELISA, and real time PCR as common techniques for their detection, respectively. Moreover, we assessed the role of +36 GFP for eliciting HPV-related anti-tumor effects in mice due to the lack of HPV replication in vitro. Results: Our data showed that +36 GFP efficiently enter the cells and augment the transfection rate of HPV16E7 antigen, as well. Furthermore, +36 GFP significantly reduced HCV, HIV and HSV replication up to 75%, 49% and 43% in HCV-infected Huh7.5 cells, HIV-infected Hela cells and HSV-infected Vero cells, respectively. On the other hand, mice immunization with +36 GFP complexed with HPV16 E7 antigen (+36GFP + E7) or fused to HPV16 E7 antigen (+36GFP-E7) elicited a higher Th1 cellular immune response with the predominant IgG2a, IgG2b, IFN-γ and Granzyme B levels than those induced by other groups. These regimens protected mice against TC-1 tumor challenge (~ 67%) compared to E7 protein alone (~ 33%). These data suggested that +36 GFP can act as an anti-viral agent at certain dose due to its high efficiency in cell penetration in vitro and in vivo. Conclusion: Generally, +36 GFP targets viral replication in vitro as well as helps to suppress the growth of HPV-related tumors in vivo.
- Open Access
- 28 August 2019
- Published by CMV Verlag in Iranian Biomedical Journal
- Vol. 24 (1) , 24-29
Co-Administration of Curcumin and Bromocriptine Nano-liposomes for Induction of Apoptosis in Lung Cancer Cells
Background: In recent years, nanotechnology with modern advances in the macromolecular design of nano-carriers has proved to be helpful in the development of drugs delivery systems. This research represents a novel co-administration of nano-vehicles, known as liposomes. Liposomes efficiently encapsulate curcumin and bromocriptine (BR) in a polymer structure, which results in enhanced aqueous ...
- 28 August 2019
- Published by CMV Verlag in Iranian Biomedical Journal
- Vol. 24 (1) , 24-29
Open AccessCo-Administration of Curcumin and Bromocriptine Nano-liposomes for Induction of Apoptosis in Lung Cancer Cells
Background: In recent years, nanotechnology with modern advances in the macromolecular design of nano-carriers has proved to be helpful in the development of drugs delivery systems. This research represents a novel co-administration of nano-vehicles, known as liposomes. Liposomes efficiently encapsulate curcumin and bromocriptine (BR) in a polymer structure, which results in enhanced aqueous ...
- 7 May 2019
- Published by Wiley in Biotechnology Progress
- Vol. 35 (5) , e2835
Cyanobacteria as an eco‐friendly resource for biofuel production: A critical review
Cyanobacteria are photosynthetic microorganisms which can be found in various environmental habitats. These photosynthetic bacteria are considered as promising feedstock for the production of the third‐ and the fourth‐generation biofuels. The main subject of this review is highlighting the significant aspects of the biofuel production from cyanobacteria. The most recent investigations about the extraction or separation of the bio‐oil from cyanobacteria are also adduced in the present review. Moreover, the genetic engineering of cyanobacteria for improving biofuel production and the impact of bioinformatics studies on the designing better‐engineered strains are mentioned. The large‐scale biofuel production is challenging, so the economic considerations to provide inexpensive biofuels are also cited. It seems that the future of biofuels is strongly dependent to the following items; understanding the metabolic pathways of the cyanobacterial species, progression in the construction of the engineered cyanobacteria, and inexpensive large‐scale cultivation of them.
- 7 May 2019
- Published by Wiley in Biotechnology Progress
- Vol. 35 (5) , e2835
Cyanobacteria as an eco‐friendly resource for biofuel production: A critical review
Cyanobacteria are photosynthetic microorganisms which can be found in various environmental habitats. These photosynthetic bacteria are considered as promising feedstock for the production of the third‐ and the fourth‐generation biofuels. The main subject of this review is highlighting the significant aspects of the biofuel production from cyanobacteria. The most recent investigations about the extraction or separation of the bio‐oil from cyanobacteria are also adduced in the present review. Moreover, the genetic engineering of cyanobacteria for improving biofuel production and the impact of bioinformatics studies on the designing better‐engineered strains are mentioned. The large‐scale biofuel production is challenging, so the economic considerations to provide inexpensive biofuels are also cited. It seems that the future of biofuels is strongly dependent to the following items; understanding the metabolic pathways of the cyanobacterial species, progression in the construction of the engineered cyanobacteria, and inexpensive large‐scale cultivation of them.
- Open Access
- 1 November 2018
- Published by CMV Verlag in Iranian Biomedical Journal
- Vol. 22 (6) , 362-366
The Productivity and Characteristics of Iranian Biomedical Journal: A Scientometric Analysis
Background: Scientometrics is a discipline that analyzes scientific publications to explore the structure and growth of science. In this work, the quantitative evaluation of the productivity of the Iranian Biomedical Journal (IBJ) is reviewed. Methods: The analysis was done based on a cross-sectional descriptive and an analytical scientometric study. Data were collected from ...
- 1 November 2018
- Published by CMV Verlag in Iranian Biomedical Journal
- Vol. 22 (6) , 362-366
Open AccessThe Productivity and Characteristics of Iranian Biomedical Journal: A Scientometric Analysis
Background: Scientometrics is a discipline that analyzes scientific publications to explore the structure and growth of science. In this work, the quantitative evaluation of the productivity of the Iranian Biomedical Journal (IBJ) is reviewed. Methods: The analysis was done based on a cross-sectional descriptive and an analytical scientometric study. Data were collected from ...
- 1 September 2014
- Published by Institute of Electrical and Electronics Engineers (IEEE)
- p. 544-549
Application and effectiveness of ontology on e-Health
With the mutual understanding of the concepts and terms and the semantic relationship, Interaction and integration between health systems, decision support systems can be easily done. Ontology is one way of overcoming the problems of interoperability. Ontology is a formal explicit description of concepts in a special domain. In this article, to review the application and effectiveness of Ontologies in e-Health, and we provided a model for the design of disease ontology. By creating an ontology for the domain Diseases, Concepts and relationships in a variety of diseases and the semantic interoperability between them can be determined. By understanding the various aspects of the Ontology application in e-Health and overcoming their weaknesses and strengths, the impact of these tools can be used in the field. However, the use of valid models of Ontology Design Disease in order to manage data and representing knowledge, creating integrated systems and interaction and Knowledge-based decision support systems in the field of e-health is very important.
- 1 September 2014
- Published by Institute of Electrical and Electronics Engineers (IEEE)
- p. 544-549
Application and effectiveness of ontology on e-Health
With the mutual understanding of the concepts and terms and the semantic relationship, Interaction and integration between health systems, decision support systems can be easily done. Ontology is one way of overcoming the problems of interoperability. Ontology is a formal explicit description of concepts in a special domain. In this article, to review the application and effectiveness of Ontologies in e-Health, and we provided a model for the design of disease ontology. By creating an ontology for the domain Diseases, Concepts and relationships in a variety of diseases and the semantic interoperability between them can be determined. By understanding the various aspects of the Ontology application in e-Health and overcoming their weaknesses and strengths, the impact of these tools can be used in the field. However, the use of valid models of Ontology Design Disease in order to manage data and representing knowledge, creating integrated systems and interaction and Knowledge-based decision support systems in the field of e-health is very important.